(Press-News.org) A study of the genetics of pericarditis increases understanding of newly approved drug treatment
Sequence variants that protect against pericarditis have been discovered at a genomic locus encoding interleukin-1 immune cytokines. A newly approved drug treatment for pericarditis inhibits these cytokines and new a study from deCODE genetics and collaborators can contribute to the further development of this treatment.
A new study called “Variants at the interleukin-1 gene locus and pericarditis” was published today in the journal JAMA Cardiology, by scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Denmark, USA, and Iceland.
The study involves a genome-wide search for variants affecting the risk of pericarditis, a disease characterized by often painful inflammation of the fibrous sack surrounding the heart. A subset of patients experiences recurrent pericarditis that does not respond well to traditional treatment with unspecific anti-inflammatory drugs. The role of specific immune processes in pericarditis is poorly understood and the aim of the study was to use human genetics to shed light on the pathogenesis of the disease.
The scientists found common variants in the genome that protect against pericarditis. They are located in a region with genes encoding interleukin-1 inflammatory cytokines. Drugs inhibiting these cytokines have previously been used to treat other inflammatory diseases and recently they have been tested in clinical studies of recurrent pericarditis with good results. One of these drugs was approved by the US Food and Drug Administration for use in recurrent pericarditis as recently as 2021.
The results of the genetic study provide important insights. They suggest that interleukin-1 may be an important contributor to pericarditis in general, as the identified variants are common (up to approximately 50% frequency). Furthermore, the results provide the foundation for future studies, such as those aimed at understanding which interleukin-1 cytokines are most important and whether response to treatment is affected by genotype.
----
Based in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using its unique expertise and population resources, deCODE has discovered genetic risk factors for dozens of common diseases. The purpose of understanding the genetics of disease is to use that information to create new means of diagnosing, treating and preventing disease. deCODE is a wholly-owned subsidiary of Amgen (NASDAQ:AMGN).
END
A study of the genetics of pericarditis increases understanding of newly approved drug treatment
2023-12-27
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
New reptile on the block: A new iguana species discovered in China
2023-12-27
A new iguana joins Asia’s rich reptile fauna, officially described as new to science in the open-access journal ZooKeys.
“From 2009 to 2022, we conducted a series of field surveys in South China and collected a number of specimens of the Calotes versicolor species complex, and found that the population of what we thought was Calotes versicolor in South China and Northern Vietnam was a new undescribed species and two subspecies,” says Yong Huang, whose team described the new species.
Wang’s garden ...
Quality of care declines after private equity takes over hospitals
2023-12-26
At a glance:
National study of quality of care in hospitals acquired by private equity shows worsening of fall and infection risk, other measures of quality and safety.
Some post-procedure adverse events increased even though private equity hospitals performed fewer procedures among younger and less disadvantaged patients.
The new findings amplify existing economic concerns about the growth of this for-profit ownership model.
Patients are more likely to fall, get new infections, or experience other forms of harm during their stay in a hospital after it is acquired by a private equity firm, according to a new ...
Changes in hospital adverse events and patient outcomes associated with private equity acquisition
2023-12-26
About The Study: Private equity acquisition of hospitals, on average, was associated with increased hospital-acquired adverse events despite a likely lower-risk pool of admitted Medicare beneficiaries, suggesting poorer quality of inpatient care. These findings heighten concerns about the implications of private equity on health care delivery.
Authors: Zirui Song, M.D., Ph.D., of Harvard Medical School in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2023.23147)
Editor’s Note: Please see the article for additional ...
Variation by institution in sexual harassment experiences among medical interns
2023-12-26
About The Study: Among a national cohort of medical interns, over half experienced sexual harassment. Although harassment was prevalent across programs, institutional and specialty training variations in interns’ sexual harassment experiences exist, thereby providing additional evidence that residency programs and institutions play an important role in combating this widespread problem.
Authors: Elizabeth M. Viglianti, M.D., M.P.H., M.Sc., of the University of Michigan in Ann Arbor, is the corresponding author.
To ...
Negative wealth shock and cognitive decline and dementia in middle-aged and older adults
2023-12-26
About The Study: In this study of 8,000 participants, negative wealth shock (a loss of 75% or more in total wealth over a 2-year period) was associated with accelerated cognitive decline and elevated risks of dementia among middle-aged and older U.S. adults, with modifications by age and ethnicity. These findings should be confirmed by further prospective and interventional studies.
Authors: Jing Guo, Ph.D., of the Zhejiang University School of Medicine in Hangzhou, China, is the corresponding author.
To access ...
Prediction of 2-year cognitive outcomes in very preterm infants using machine learning methods
2023-12-26
About The Study: The findings of this prognostic study of cognitive outcomes at 2-year follow-up among 1,000 infants born very preterm suggest that predictive modeling in neonatal care could enable early and targeted intervention for very preterm infants most at risk for developing cognitive impairment.
Authors: Andrea K. Bowe, M.B., M.P.H., of University College Cork in Cork, Ireland, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.49111)
Editor’s Note: Please see the article for additional information, including other authors, ...
Pet ownership, living alone, and cognitive decline among adults age 50 and older
2023-12-26
About The Study: Pet ownership was associated with slower rates of decline in verbal memory and verbal fluency among older adults living alone, but not among those living with others in this study of 7,900 participants age 50 and older. Pet ownership offset the associations between living alone and declining rates in verbal memory and verbal fluency. Further studies are needed to assess whether pet ownership slows the rate of cognitive decline in older adults living alone.
Authors: Ciyong Lu, Ph.D., of Sun Yat-sen University in Guangzhou, China, is the corresponding author.
To ...
Scientists use organoid model to identify potential new pancreatic cancer treatment
2023-12-26
A drug screening system that models cancers using lab-grown tissues called organoids has helped uncover a promising target for future pancreatic cancer treatments, according to a new study from researchers at Weill Cornell Medicine.
In the study, published Dec. 26 in Cell Stem Cell, the scientists tested more than 6,000 compounds on their pancreatic tumor organoids, which contain a common pancreatic cancer-driving mutation. They identified one compound—an existing heart drug called perhexiline maleate—that powerfully suppresses ...
Risk of young-onset dementia could be reduced through targeting health and lifestyle factors - study
2023-12-26
December 21 Peer reviewed /observational study / in people*
Strictly embargoed 4PM UK time on Tuesday December 26
Researchers have identified a wide range of risk factors for young-onset dementia. The findings challenge the notion that genetics are the sole cause of the condition, laying the groundwork for new prevention strategies.
The largescale study identified 15 risk factors, which are similar to those for late-onset dementia. For the first time, they indicate that it may be possible to reduce the risk of young-onset dementia ...
In situ characterization reveals different dehydrogenation pathways in MgH2
2023-12-26
They published their work on Dec. 20 in Energy Material Advances.
"Economic, efficient, and safe hydrogen storage methods play a crucial role in exploiting hydrogen energy, reducing carbon emissions, and improving the utilization efficiency of renewable clean energies," said paper author Jianxin Zou, professor in National Engineering Research Center of Light Alloys Net Forming & State Key Laboratory of Metal Matrix Composites. "Solid-state hydrogen storage in hydrides has been considered as a promising hydrogen storage technology. Although the industrial ...